Champions Oncology, Inc.
(NASDAQ : CSBR)

( )
CSBR PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Binary Options?
We'll teach you the best ways to trade binaries.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen Inc.
0.38%194.911.2%$602.16m
GILDGilead Sciences, Inc.
-0.78%67.480.9%$499.30m
CELGCelgene Corporation
-0.19%69.271.2%$492.42m
BIIBBiogen Inc.
0.01%319.251.3%$467.66m
ILMNIllumina, Inc.
-5.73%301.593.5%$381.70m
REGNRegeneron Pharmaceuticals, Inc.
0.00%338.982.6%$298.66m
VRTXVertex Pharmaceuticals Incorporated
-2.45%161.071.9%$260.54m
ALXNAlexion Pharmaceuticals, Inc.
-3.00%115.062.0%$199.08m
AAgilent Technologies, Inc.
-3.72%62.571.5%$185.86m
SRPTSarepta Therapeutics, Inc.
-2.25%116.3615.4%$146.77m
LGNDLigand Pharmaceuticals Incorporated
-3.83%148.5423.3%$139.57m
EXASExact Sciences Corporation
0.00%67.2825.3%$137.02m
NKTRNektar Therapeutics
-0.58%38.015.6%$122.24m
INCYIncyte Corporation
-3.40%64.252.5%$115.74m
TSROTESARO, Inc.
-0.41%36.6814.4%$108.95m

Company Profile

Champions Oncology, Inc. engages in the development and sale of technology solutions and products to personalize the development and use of oncology drugs. Its technology platform, TumorGraft, is a novel approach to personalizing cancer care based upon the implantation of human tumors in immune-deficient mice. It uses its technology to offer solutions to Translational Oncology Solutions, which includes pharmaceutical and biotechnology companies; and Personalized Oncology, which assists physicians in developing personalized treatment options for their cancer patients. The company was founded by James M. Martell and David Sidransky on June 4, 1985 and is headquartered in Hackensack, NJ.